Cork, Michael J., et al. “Clinically Meaningful Responses to Dupilumab Among Children Aged 6 Months to 5 Years With Moderate-to-Severe Atopic Dermatitis Who Did Not Achieve Clear or Almost Clear Skin According to the Investigator’s Global Assessment: A Post Hoc Analysis of a Phase 3 Trial”. Acta Dermato-Venereologica, vol. 104, Feb. 2024, p. adv13467, doi:10.2340/actadv.v104.13467.